tan kesselheim - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2013	1
2014	2
2015	1
2020	0

Page 1

The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.

Kesselheim AS, Tan YT, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2015 Feb;34(2):286-93. doi: 10.1377/hlthaff.2014.1038. Health Aff (Millwood). 2015. PMID: 25646109

Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.

Kramer DB, Tan YT, Sato C, Kesselheim AS. Kramer DB, et al. Food Drug Law J. 2014;69(1):1-23, i. Food Drug Law J. 2014. PMID: 24772683 Free PMC article.

Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China.

Kramer DB, Tan YT, Sato C, Kesselheim AS. Kramer DB, et al. PLoS Med. 2013;10(9):e1001519. doi: 10.1371/journal.pmed.1001519. Epub 2013 Sep 24. PLoS Med. 2013. PMID: 24223035 Free PMC article.

Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs.

Kesselheim AS, Tan YT, Darrow JJ, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2014 Oct;33(10):1770-8. doi: 10.1377/hlthaff.2014.0529. Health Aff (Millwood). 2014. PMID: 25288421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results